ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.40%
      US Tech 100
      19,578.80
      0.00%
      Dow Jones
      42,175.11
      0.62%
      Brent Oil
      71.335
      0.54%
      Bitcoin
      65,439.66
      0.39%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Verve Therapeutics Inc (VERV)

      7. Verve Therapeutics Inc (VERV) Financials

      Verve Therapeutics Inc

      Verve Therapeutics Inc (VERV)

      Verbund Ag
      Verbund Ag
      Verbund Ag
      Verbund Ag
      4.96
      0.00
      (0.00%)
      Closed September 27 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Verve Therapeutics Inc Financial Summary

      The current VERV market cap is 419.74M. The company's latest EPS is USD -2.3642 and P/E is -2.10.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.09M3.12M5.14M5.7M6.69M
      Operating Income -58.58M-52.33M-53.95M-56.84M-58.84M
      Net Income -53.98M-45.76M-48.35M-48.74M-49.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0001.94M11.76M
      Operating Income -13.64M-40.63M-87.07M-165.69M-223.12M
      Net Income -19.3M-45.7M-120.31M-157.39M-200.07M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 589.13M612.41M752.69M732.36M700.91M
      Total Liabilities 123.91M152.04M153.19M149.29M154.82M
      Total Equity 465.22M460.37M599.5M583.07M546.09M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 21.65M78.41M384.12M679.22M752.69M
      Total Liabilities 15.72M17.16M26.77M128.29M153.19M
      Total Equity -19.55M-63.91M357.35M550.93M599.5M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -97.06M-108.87M-149.55M-43.08M-77.24M
      Investing 48.42M36.58M27.69M-41.63M-11.48M
      Financing 3.27M35.19M212.58M22.73M24.03M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -7.44M-35.27M-77.88M-122.33M-149.55M
      Investing -12.76M-51.13M-239.1M-155.96M27.69M
      Financing 17.95M92.63M377.09M328.96M212.58M

      Stats and Ratios

      Market Cap 419.74M
      Price to Earnings Ratio -2.10
      Price to Sales Ratio 35.71
      Price to Cash Ratio 2.04
      Price to Book Ratio 0.7
      Dividend Yield -

      Share Statistics

      Shares Outstanding 84.62M
      Average Volume (1 week) 1.49M
      Average Volume (1 Month) 1.44M
      52 Week Change -62.62%
      52 Week High 20.12
      52 Week Low 4.305
      Spread (Intraday) 0.02 (0.4%)

      Company Info

      Company Name Verve Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.vervetx.com
      Industry pharmaceutical preparations (2834)